Catégorie : Communiqué de presse

GlycoNet startup, ABOzymes, completes seed financing round to fund development of technology to enable universal organ transplants and blood transfusions

GlycoNet startup, ABOzymes, completes seed financing round to fund development of technology to enable universal organ transplants and blood transfusions

Glycomics is an integral part of ABOzymes’ life-saving research and technology development.

GlycoNet partner company, Alectos Therapeutics, enters ground-breaking $700 million agreement with Biogen

GlycoNet partner company, Alectos Therapeutics, enters ground-breaking $700 million agreement with Biogen

This collaboration combines Alectos’ expertise in small-molecule therapeutics with Biogen’s development capabilities in movement disorders.

GlycoNet joins national industry association to drive economic growth in the biotechnology sector

GlycoNet joins national industry association to drive economic growth in the biotechnology sector

As a member of BIOTECanada’s network, GlycoNet aims to mobilize glycomics research into tangible and sustainable innovation for Canadians.

GlycoNet and BridgeBio Pharma Inc. initiate collaboration to discover potential treatments for genetic diseases through glycomics research

GlycoNet and BridgeBio Pharma Inc. initiate collaboration to discover potential treatments for genetic diseases through glycomics research

Genetic disease research has benefitted substantially from the study of glycomics, which relates to the functions of glycans, or sugar, in biological systems

Canadian Glycomics Network launches Call for Proposals for glycomics projects to address fundamental health challenges in Canada

Canadian Glycomics Network launches Call for Proposals for glycomics projects to address fundamental health challenges in Canada

The Network will commit $1.8 million in glycomics to support made-in-Canada health innovations and build a sustainable national bioeconomy

GlycoNet start-up PanTHERA CryoSolutions receives up to $4 million investment to advance technologies in regenerative medicine

GlycoNet start-up PanTHERA CryoSolutions receives up to $4 million investment to advance technologies in regenerative medicine

The made-in-Canada technology is revolutionizing the cryopreservation of cell and tissues.

fr_CAFrench
Scroll to Top